Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

BG 00012

Known as: 00012, BG, BG-00012, BG00012 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Objective: To evaluate the mechanism of action of dimethylfumarate (DMF), a novel oral therapeutic for the treatment of multiple… Expand
Is this relevant?
Highly Cited
2011
Highly Cited
2011
Inflammation and oxidative stress are thought to promote tissue damage in multiple sclerosis. Thus, novel therapeutics enhancing… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
Review
2010
Review
2010
Importance of the field: One of the disadvantages of currently available disease-modifying drugs (DMDs) for multiple sclerosis… Expand
Is this relevant?
Highly Cited
2008
Highly Cited
2008
BACKGROUND Oral fumarate (BG00012) might have dual anti-inflammatory and neuroprotective effects. Our aim was to assess the… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?
2008
2008
Traditional disease-modifying therapies (DMTs) for MS have pleiotropic effects on the disease pathophysiology including… Expand
Is this relevant?